Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
International Institute for Population Sciences, Mumbai, India.
Asian Pac J Cancer Prev. 2021 Mar 1;22(3):793-800. doi: 10.31557/APJCP.2021.22.3.793.
Cancer treatment during nationwide lockdown due to the COVID-19 pandemic has posed several challenges in the delivery of cancer care and carries tremendous potential sequel of impoverishing the households. This study aims to examine the economic distress faced by breast cancer patients receiving treatment at Tata Memorial Center (TMC) Mumbai, India during the nationwide lockdown initiated in March 2020 following the outbreak of COVID-19.
A total of 138 non-metastatic breast cancer patients who were accrued in this study at TMC before imposing of lockdown, and their treatment was impacted because of the COVID-19 outbreak, were interviewed. Telephonic interviews were conducted using a structured schedule which contained information on household and demographic characteristics of the patients, knowledge about COVID-19, their daily expenditure for treatment, difficulties faced during lockdown and how they met expenditures. Descriptive statistics and logistic regression were used in the analyses.
The average monthly expenditure of cancer patients had increased by 32% during the COVID-19 period while the mean monthly household income was reduced by a quarter. More than two-thirds of the patients had no income during the lockdown. More than half of the patients met their expenditure by borrowing money, 30% of the patients used their savings, 28% got charity and 25% used household income. About 81% of the patients had reported shortage of money, 32% reported shortage of food and 28% reported shortage of medicine. The distress financing was significantly higher among patients receiving treatment in Mumbai compared to those receiving treatment at their native cities (67% vs. 46%), patients under 40 years of age, illiterate, currently married, Muslim and staying at a rented house.
The incremental expenditure coupled with reduced or no income due to the closure of economic activities in the country imposed severe financial stress on breast cancer patients.
由于 COVID-19 大流行而实行的全国性封锁对癌症治疗带来了一些挑战,这对癌症患者家庭造成了极大的经济负担。本研究旨在探讨 2020 年 3 月 COVID-19 爆发后,印度塔塔纪念中心(TMC)接受治疗的乳腺癌患者所面临的经济困境。
本研究共纳入了 138 名在 TMC 登记的非转移性乳腺癌患者,这些患者在封锁前就已经登记,由于 COVID-19 疫情,他们的治疗受到了影响。采用结构化的访谈提纲对患者进行电话访谈,内容包括患者的家庭和人口统计学特征、对 COVID-19 的了解、治疗期间的日常支出、封锁期间面临的困难以及如何支付费用等。采用描述性统计和逻辑回归进行分析。
在 COVID-19 期间,癌症患者的月平均支出增加了 32%,而月平均家庭收入减少了四分之一。超过三分之二的患者在封锁期间没有收入。超过一半的患者通过借款来支付费用,30%的患者使用储蓄,28%的患者获得慈善援助,25%的患者使用家庭收入。约 81%的患者报告资金短缺,32%的患者报告食物短缺,28%的患者报告药物短缺。与在原籍城市接受治疗的患者相比,在孟买接受治疗的患者的应急融资显著更高(67% vs. 46%),且患者年龄在 40 岁以下、文盲、已婚、穆斯林以及租房居住的患者比例更高。
由于国家经济活动的关闭导致的额外支出以及收入的减少或丧失,给乳腺癌患者带来了严重的经济压力。